These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2474039)

  • 1. Equine interferons following exposure to equid herpesvirus-1 or -4.
    Edington N; Bridges CG; Griffiths L
    J Interferon Res; 1989 Aug; 9(4):389-92. PubMed ID: 2474039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia.
    Perkins G; Babasyan S; Stout AE; Freer H; Rollins A; Wimer CL; Wagner B
    Virology; 2019 May; 531():219-232. PubMed ID: 30928700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses.
    Wimer CL; Schnabel CL; Perkins G; Babasyan S; Freer H; Stout AE; Rollins A; Osterrieder N; Goodman LB; Glaser A; Wagner B
    PLoS One; 2018; 13(11):e0206679. PubMed ID: 30440016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
    Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B
    BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immunity during Equid herpesvirus 1 (EHV-1) infection.
    Bridges CG; Edington N
    Clin Exp Immunol; 1986 Jul; 65(1):172-81. PubMed ID: 2431815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses.
    Giessler KS; Goehring LS; Jacob SI; Davis A; Esser MM; Lee Y; Zarski LM; Weber PSD; Hussey GS
    J Gen Virol; 2024 May; 105(5):. PubMed ID: 38767608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equine herpesvirus-1 infected peripheral blood mononuclear cell subpopulations during viremia.
    Wilsterman S; Soboll-Hussey G; Lunn DP; Ashton LV; Callan RJ; Hussey SB; Rao S; Goehring LS
    Vet Microbiol; 2011 Apr; 149(1-2):40-7. PubMed ID: 21093993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
    Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R
    Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical signs and humoral immune response in horses following equine herpesvirus type-1 infection and their susceptibility to equine herpesvirus type-4 challenge.
    Stokes A; Corteyn AH; Murray PK
    Res Vet Sci; 1991 Sep; 51(2):141-8. PubMed ID: 1664967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia.
    van der Meulen K; Caij B; Pensaert M; Nauwynck H
    Vet Microbiol; 2006 Mar; 113(3-4):265-73. PubMed ID: 16387454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of ponies with the IE gene of EHV-1 in a recombinant modified live vaccinia vector protects against clinical and virological disease.
    Soboll G; Breathnach CC; Kydd JH; Hussey SB; Mealey RM; Lunn DP
    Vet Immunol Immunopathol; 2010 May; 135(1-2):108-117. PubMed ID: 20018383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine responses to EHV-1 infection in immune and non-immune ponies.
    Coombs DK; Patton T; Kohler AK; Soboll G; Breathnach C; Townsend HG; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):109-16. PubMed ID: 16473413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma D-dimer concentrations during experimental EHV-1 infection of horses.
    Goehring LS; Soboll Hussey G; Gomez Diez M; Benedict K; Maxwell LK; Morley PS; Sloet van Oldruitenborgh-Oosterbaan MM; Lunn DP
    J Vet Intern Med; 2013; 27(6):1535-42. PubMed ID: 24112533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One way protection between equid herpesvirus 1 and 4 in vivo.
    Edington N; Bridges CG
    Res Vet Sci; 1990 Mar; 48(2):235-9. PubMed ID: 2159176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and quantification of equine herpesvirus-1 viremia and nasal shedding by real-time polymerase chain reaction.
    Hussey SB; Clark R; Lunn KF; Breathnach C; Soboll G; Whalley JM; Lunn DP
    J Vet Diagn Invest; 2006 Jul; 18(4):335-42. PubMed ID: 16921871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
    Platt R; Sponseller BA; Chiang YW; Roth JA
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant.
    Soboll Hussey G; Hussey SB; Wagner B; Horohov DW; Van de Walle GR; Osterrieder N; Goehring LS; Rao S; Lunn DP
    Vet Res; 2011 Feb; 42(1):23. PubMed ID: 21314906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated cytolysis of equine herpesvirus-infected cells by leukocytes from young vaccinated horses.
    Ellis JA; Steeves E; Wright AK; Bogdan JR; Davis WC; Kanara EW; Haines DM
    Vet Immunol Immunopathol; 1997 Jul; 57(3-4):201-14. PubMed ID: 9261959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cytotoxicity of serum and peripheral blood leukocytes for equine herpesvirus type 1-infected target cells.
    Wilks CR
    Am J Vet Res; 1977 Jan; 38(1):117-21. PubMed ID: 189645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.